Pressroom

See all trending topics »Trending Topics

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator »

Memorial Sloan Kettering Study Finds Robotic Surgery No Better Than Open Procedure for Bladder Cancer

Physicians at Memorial Sloan Kettering have found that robotic surgery to remove a cancerous bladder did not reduce the risk of complications as compared with traditional open surgery. Findings were published this week in the New England Journal of Medicine. The study was conducted at MSK with surgeons experienced in both procedures and raises questions about the cost effectiveness of robotic surgery. For more information and to set up interviews with Dr. Bernard Bochner or Dr. Vincent Laudone, please contact Emily O’Donnell at odonnele@mskcc.org.

Thursday, July 24, 2014
Memorial Sloan Kettering Ranks First in the Nation for Cancer Care

Memorial Sloan Kettering is proud and honored to announce it has been named the number one hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals. Since the inception of the revered list 25 years ago, MSK has held either the first or second spot each year.

Tuesday, July 15, 2014
New Research at the 2014 ASCO Annual Meeting

Memorial Sloan Kettering experts are available to comment on research presented at the 2014 annual meeting of the American Society of Clinical Oncology, including research in immunotherapy and targeted therapy, as well as breast, prostate, colorectal, and lung cancers, among others. For more information and to set up interviews or access photos and video, email Caitlin Hool at hoolc@mskcc.org.

Friday, May 30, 2014

See all press releases »Press Releases

Memorial Sloan Kettering Ranks First in the Nation for Cancer Care

Memorial Sloan Kettering Cancer Center is proud and honored to announce it has been named the number one hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals.

Tuesday, July 15, 2014
Memorial Sloan Kettering Appoints DigitasLBi as Digital Agency of Record Phase2 Selected as Drupal Technology Partner

Memorial Sloan Kettering Cancer Center (MSK) is partnering with DigitasLBi and Phase2 to help expand MSK’s digital reach.

Thursday, June 19, 2014
Memorial Sloan Kettering Cancer Center and Quest Diagnostics Partner to Advance Precision Medicine in Cancer Diagnosis and Treatment

Memorial Sloan Kettering and Quest Diagnostics announced a joint collaboration that will utilize MSK’s clinical and research insights into gene mutations associated with solid tumors.

Sunday, June 1, 2014

See all story starters »Story Starters

Need story ideas? Use our evergreen story suggestions to generate new content or complement something you're already working on.

See all blog posts »On Our Blog

In the Lab
Compound from Tropical Plant Targets Key Cancer-Causing Genes

Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC, a cancer-causing gene that has remained elusive until now.

Monday, July 28, 2014
Pictured: Anna Skripnik & Kathryn Ciccollini
Feature
Spotlight on Dermatology Nursing

Today, we spotlight our dermatology nurses. Learn more about them.

Friday, July 25, 2014
Pictured: Robotic surgery
In the Clinic
Study Shows Robotic Surgery Holds No Major Advantages for Bladder Cancer Patients

Memorial Sloan Kettering researchers have found that the use of surgical robots does not lead to better outcomes in patients undergoing radical cystectomy for bladder cancer, bringing into question the added costs of the tools.

Thursday, July 24, 2014

MSK News Highlights

Watch highlights including news coverage of recent scientific and clinical developments at Memorial Sloan Kettering, our physicians and scientists in the national spotlight, and our amazing staff and programs.

Watch Video »

See all media coverage »Media Coverage

Sloan Kettering Gets $100 Million Gift

Memorial Sloan Kettering received a landmark gift of $100 million to undertake a unique and intensive endeavor to transform cancer care through genomic analysis of patient-derived tumors. President and CEO Craig Thompson was interviewed.

Friday, June 20, 2014
Bristol-Myers Squibb: Big Pharma's Small Wonder

Melanoma and Immunotherapeutics Service Chief Jedd Wolchok commented on the immunotherapy drug ipilimumab (Yervoy™) for patients with advanced melanoma.

Monday, June 16, 2014
Teens Who Overcame Cancer Get Special Graduation Ceremony at Memorial Sloan Kettering Cancer Center

Pediatric oncologist Paul Meyers was interviewed about Memorial Sloan Kettering’s annual high school graduation ceremony for former pediatric cancer patients.

Friday, June 13, 2014

For Journalists

Contact Media Staff

Jeanne D'Agostino
Media Relations Manager
Emily O'Donnell
Senior Communications Associate, Department of Surgery
Courtney Nowak
Senior Media Relations Associate
Caitlin Hool
Senior Media Associate
Andrea Baird
Media Associate

For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.

After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

Subscribe to Our
E-Newsletter

Our e-mail newsletter for journalists offers the latest advances in cancer research and treatment, including story ideas, institutional milestones and plans, and newsworthy staff accomplishments.

Sign Up

Read recent issues »